Prof M. Maemondo
Shimotsuke, 3290498, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 137 publications
Association Between EGFR Mutation Status and Out-of-field Recurrence in Locally Advanced Unresectable Non-small Cell Lung Cancer Treated With Chemoradiotherapy and Durvalumab Consolidation.
Journal: Anticancer research
Published: June 03, 2026
Negative-pressure pumping fluid as a cytological specimen for bronchoscopic diagnosis and molecular testing in lung cancer.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: May 20, 2026
Clinical factors and practical strategies to optimize amikacin liposome inhalation suspension therapy in refractory Mycobacterium avium complex pulmonary disease.
Journal: BMC pulmonary medicine
Published: March 11, 2026
Comparison of anthracycline plus platinum versus other platinum-based regimens as first-line chemotherapy for untreated thymoma: A retrospective cohort study (NEJ023B).
Journal: Lung cancer (Amsterdam, Netherlands)
Published: January 29, 2026
Role of Upregulated Mucin 21 in Detached Lung Cancer Cells.
Journal: Pathology international
Published: December 29, 2025
Real-world comparative effectiveness of atezolizumab versus durvalumab for extensive-stage small-cell lung cancer.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: December 15, 2025
Clinical characteristics and systemic treatment in patients with elderly-onset sarcoidosis: A retrospective single-centre study in Japan.
Journal: Respiratory investigation
Published: December 10, 2025
Retrospective study of alectinib treatment among variants of ALK fusion in lung adenocarcinoma.
Journal: Translational lung cancer research
Published: November 06, 2025
Immune-mediated inflammatory diseases associated with sarcoidosis: A case-control study in Japan.
Journal: Respiratory medicine
Published: September 22, 2025
A Phase 2 Study of Osimertinib in Combination With Platinum-Pemetrexed in Patients With Uncommon Epidermal Growth Factor Receptor-Mutated Advanced Non-Small Cell Lung Cancer (NEJ067/OPAL2).
Journal: Clinical lung cancer
Published: May 01, 2025
A phase II study of afatinib in combination with pemetrexed and carboplatin in patients with EGFR mutation-positive non-squamous, advanced non-small cell lung cancer (NSCLC) refractory to first-line osimertinib treatment: NEJ025B study.
Journal: European journal of cancer (Oxford, England : 1990)
Published: April 26, 2025
Last Updated: 09/26/2026